Search results: Sage Journals

Restricted accessResearch articleFirst published November, 2015

IL-17A,IL-22,and IL-23 as Markers of Psoriasis Activity

Christina Fotiadou, Elizabeth Lazaridou, Eleni Sotiriou [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessResearch articleFirst published May, 2019

The meaning of youth physical activity experiences among individuals with psoriasis: A retrospective inquiry

Justin A Haegele, Patrick B Wilson, Xihe Zhu [...]

European Physical Education Review

Restricted accessReview articleFirst published 2024

The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis

Xiran Lin, Xianmin Meng, Jingrong Lin

Journal of Cutaneous Medicine and Surgery

Restricted accessBrief reportFirst published January, 2021

Does Antibiotic Therapy Affect Time to Clearance in Post-Active Phase Streptococcal Guttate Psoriasis—A Case Control Study

Joshua Farrell, Thomas Jonathan Stewart, Robert Howard Rosen

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published July, 2023

Psoriasis Involving Special Areas is Associated with Worse Quality of Life,Depression,and Limitations in the Ability to Participate in Social Roles and Activities

Andrew Blauvelt, George C. Gondo, Stacie Bell [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessCase reportFirst published 2023

The use of interleukin-23 inhibitors to treat immune-related psoriasis induced by immune checkpoint inhibitors and in patients with active cancer: A case series and review of the literature

Cynthia Fournier, Marcus Otho Butler, Maxwell Benjamin Sauder

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published March, 2022

Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer

Pui Yee Wong, Soon Hin How, Irnani Ismail [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published March, 2003

Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes

A B Gottlieb

Lupus

Open accessResearch articleFirst published 2023

Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions

Kesara Na-Bangchang, Monthaka Teerachaisakul, Phunuch Muhamad [...]

Journal of Evidence-Based Integrative Medicine

Free accessResearch articleFirst published April, 2008

Effect of Efalizumab on Neutrophil and Monocyte Functions in Patients with Psoriasis

F. Capsoni, A.M. Ongari, E. Frigerio [...]

International Journal of Immunopathology and Pharmacology

Restricted accessResearch articleFirst published November, 2015

IL-17A,IL-22,and IL-23 as Markers of Psoriasis Activity

Christina Fotiadou, Elizabeth Lazaridou, Eleni Sotiriou [...]

Journal of Cutaneous Medicine and Surgery

Restricted accessResearch articleFirst published May, 2019

The meaning of youth physical activity experiences among individuals with psoriasis: A retrospective inquiry

Justin A Haegele, Patrick B Wilson, Xihe Zhu [...]

European Physical Education Review

Restricted accessReview articleFirst published 2024

The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis

Xiran Lin, Xianmin Meng, Jingrong Lin

Journal of Cutaneous Medicine and Surgery

Restricted accessBrief reportFirst published January, 2021

Does Antibiotic Therapy Affect Time to Clearance in Post-Active Phase Streptococcal Guttate Psoriasis—A Case Control Study

Joshua Farrell, Thomas Jonathan Stewart, Robert Howard Rosen

Journal of Psoriasis and Psoriatic Arthritis®

Restricted accessResearch articleFirst published July, 2023

Psoriasis Involving Special Areas is Associated with Worse Quality of Life,Depression,and Limitations in the Ability to Participate in Social Roles and Activities

Andrew Blauvelt, George C. Gondo, Stacie Bell [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open accessCase reportFirst published 2023

The use of interleukin-23 inhibitors to treat immune-related psoriasis induced by immune checkpoint inhibitors and in patients with active cancer: A case series and review of the literature

Cynthia Fournier, Marcus Otho Butler, Maxwell Benjamin Sauder

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published March, 2022

Single dose of atezolizumab plus chemotherapy in active psoriasis with advanced non-small cell lung cancer

Pui Yee Wong, Soon Hin How, Irnani Ismail [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published March, 2003

Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes

A B Gottlieb

Lupus

Open accessResearch articleFirst published 2023

Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions

Kesara Na-Bangchang, Monthaka Teerachaisakul, Phunuch Muhamad [...]

Journal of Evidence-Based Integrative Medicine

Free accessResearch articleFirst published April, 2008

Effect of Efalizumab on Neutrophil and Monocyte Functions in Patients with Psoriasis

F. Capsoni, A.M. Ongari, E. Frigerio [...]

International Journal of Immunopathology and Pharmacology